Beck J L, Hopman A H, Feitz W F, Schalken J, Schaafsma H E, Van de Kaa C A, Ramaekers F C, Hanselaar A G, De Wilde P C
Department of Pathology, University Hospital Nijmegen, The Netherlands.
J Pathol. 1995 Jun;176(2):123-35. doi: 10.1002/path.1711760205.
Alcohol-fixed single cell suspensions of 37 renal cell carcinomas (RCCs) were assessed by both flow cytometry (FCM) and the fluorescence in situ hybridization (FISH) technique, using chromosome 1- and chromosome 7-specific centromere DNA probes. DNA diploidy or near-diploidy was observed in 30 of the 37 RCCs and only 12 of these (near-)diploid tumours were disomic for both chromosomes 1 and 7. Numerical aberrations of chromosome 1 and/or chromosome 7 were present in 18 of the 30 (near-)diploid RCCs and five of these cases showed monosomy for chromosome 1 in more than 50 per cent of the tumour cells. A double target FISH, with a centromeric and a telomeric specific probe for 1p36, excluded misinterpretation on the basis of clustering of 1q12, and suggested a complete loss of chromosome 1. All these five (near-)diploid RCCs with monosomy for chromosome 1 were eosinophilic chromophilic cell carcinomas, according to the Thoenes classification of RCC. This observation is of special interest, because it was recently concluded from cytogenetic studies that the diagnosis of chromophilic renal cell carcinoma must be considered as obsolete. Monosomy for chromosome 1 seems to be a non-random numerical aberration of (near-)diploid eosinophilic chromophilic cell carcinomas, and a gain of one or more chromosomes 1 appeared to be a common phenomenon in RCCs, especially in the DNA aneuploid tumours. As these chromosomal abnormalities were not found in the earlier classical cytogenetic studies, we conclude that in situ hybridization techniques are required in addition to chromosome banding techniques to obtain a complete characterization of the chromosome imbalances in RCCs.
采用针对1号染色体和7号染色体着丝粒DNA的探针,通过流式细胞术(FCM)和荧光原位杂交(FISH)技术对37例肾细胞癌(RCC)的酒精固定单细胞悬液进行了评估。在37例RCC中,有30例观察到DNA二倍体或近二倍体,其中只有12例(近)二倍体肿瘤的1号和7号染色体均为二体。在30例(近)二倍体RCC中,18例存在1号和/或7号染色体的数目畸变,其中5例在超过50%的肿瘤细胞中表现为1号染色体单体。用针对1p36的着丝粒和端粒特异性探针进行的双靶点FISH排除了基于1q12聚集的错误解读,并提示1号染色体完全缺失。根据RCC的Thoenes分类,所有这5例1号染色体单体的(近)二倍体RCC均为嗜酸性嗜色细胞癌。这一观察结果特别有趣,因为最近从细胞遗传学研究得出结论,嗜色性肾细胞癌的诊断必须被视为过时。1号染色体单体似乎是(近)二倍体嗜酸性嗜色细胞癌的一种非随机数目畸变,而1号染色体一条或多条的增加似乎是RCC中的常见现象,尤其是在DNA非整倍体肿瘤中。由于这些染色体异常在早期经典细胞遗传学研究中未被发现,我们得出结论,除了染色体显带技术外,还需要原位杂交技术来全面表征RCC中的染色体失衡。